HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,051 | +4.3% | 9,083 | -7.3% | 0.01% | 0.0% |
| Q2 2023 | $1,008 | -31.1% | 9,797 | -26.9% | 0.01% | -28.6% |
| Q1 2023 | $1,463 | -12.3% | 13,406 | -8.5% | 0.01% | -22.2% |
| Q4 2022 | $1,668 | -99.8% | 14,657 | -9.7% | 0.01% | +50.0% |
| Q3 2022 | $1,004,000 | -12.7% | 16,228 | +12.5% | 0.01% | 0.0% |
| Q2 2022 | $1,150,000 | -30.1% | 14,424 | -7.8% | 0.01% | -25.0% |
| Q1 2022 | $1,645,000 | -21.2% | 15,637 | -19.3% | 0.01% | -11.1% |
| Q4 2021 | $2,088,000 | +3.3% | 19,378 | +5.0% | 0.01% | -10.0% |
| Q3 2021 | $2,021,000 | +4.0% | 18,454 | -11.1% | 0.01% | +11.1% |
| Q2 2021 | $1,943,000 | +208.9% | 20,752 | +141.2% | 0.01% | +125.0% |
| Q4 2020 | $629,000 | +50.8% | 8,605 | +60.2% | 0.00% | +33.3% |
| Q3 2020 | $417,000 | +34.5% | 5,371 | -48.7% | 0.00% | 0.0% |
| Q1 2020 | $310,000 | – | 10,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |